JP Morgan Put 330 GOS 21.06.2024/ DE000JQ5A6C9 /
24/05/2024 08:32:43 | Chg.- | Bid09:00:09 | Ask09:00:09 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.001EUR | - | - Bid Size: - |
- Ask Size: - |
GOLDMAN SACHS GRP IN... | 330.00 - | 21/06/2024 | Put |
GlobeNewswire
17:55
Sterling Check Corp. Investigated by Block & Leviton; Investors Are Encouraged to Contact the Firm
GlobeNewswire
14:00
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
13:30
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
13:00
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
13:00
Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare C...
GlobeNewswire
13:00
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
13:00
Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
13:00
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
04/06
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
04/06
Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
04/06
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
04/06
Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
09/05
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
11/04
C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties